# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
https://www.justice.gov/opa/pr/semler-scientific-inc-and-bard-peripheral-vascular-inc-pay-nearly-37m-resolve-false-claims
Benchmark analyst Mark Palmer maintains Semler Scientific (NASDAQ:SMLR) with a Buy and lowers the price target from $101 to ...
-SEC Filing
Shares of biotech company Semler Scientific Inc. (NASDAQ:SMLR) are trading higher Monday after Bitcoin (CRYPTO: BTC) asset mana...
Maxim Group analyst Matt Galinko maintains Semler Scientific (NASDAQ:SMLR) with a Buy and lowers the price target from $95 t...